TETRAFIBRICIN, A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST: I. TAXONOMY, FERMENTATION, ISOLATION, CHARACTERIZATION AND BIOLOGICAL ACTIVITIES

Tetrafibricin is a novel fibrinogen receptor antagonist produced by Streptomyces neyagawaensis NR0577. It was isolated from the culture broth by Diaion HP-21 adsorption, MeOH extraction, MCI GEL CHP-20P column chromatography, preparative HPLC and Toyopearl HW-40 SF column chromatography. The physico...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antibiotics 1993/07/25, Vol.46(7), pp.1039-1046
Hauptverfasser: KAMIYAMA, TSUTOMU, UMINO, TAKAYUKI, FUJISAKI, NORIKO, FUJIMORI, KUMIKO, SATOH, TOMOKO, YAMASHITA, YUKO, OHSHIMA, SHOICHI, WATANABE, JUNKO, YOKOSE, KAZUTERU
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1046
container_issue 7
container_start_page 1039
container_title Journal of antibiotics
container_volume 46
creator KAMIYAMA, TSUTOMU
UMINO, TAKAYUKI
FUJISAKI, NORIKO
FUJIMORI, KUMIKO
SATOH, TOMOKO
YAMASHITA, YUKO
OHSHIMA, SHOICHI
WATANABE, JUNKO
YOKOSE, KAZUTERU
description Tetrafibricin is a novel fibrinogen receptor antagonist produced by Streptomyces neyagawaensis NR0577. It was isolated from the culture broth by Diaion HP-21 adsorption, MeOH extraction, MCI GEL CHP-20P column chromatography, preparative HPLC and Toyopearl HW-40 SF column chromatography. The physico-chemical properties of tetrafibricin indicated that the structure of tetrafibricin is different from the known peptide fibrinogen receptor antagonists and closely related to the polyene macrolide antibiotics. Tetrafibricin strongly inhibited the binding of fibrinogen to its receptors with an IC50 of 46 nM. It also inhibited ADP-, collagen-, and thrombin-induced aggregation of human platelets with IC50s of 5.6, 11.0 and 7.6μM, respectively.
doi_str_mv 10.7164/antibiotics.46.1039
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75917371</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75917371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4609-868db4e3a9330d9344b8c711ab790b16b0513e44d7e632251a1864cd9d7eb5cb3</originalsourceid><addsrcrecordid>eNpNkF9PwjAUxRujQUQ_gTHZg_HJYS_t-udxkoFLyGZw-tq0XdGRAbqOB7-9Qwjh5d7knt-9pz0I3QIecmD0Sa_bylSbtrJ-SNkQMJFnqA9CQAiUyXPUx3gEoRAjfImuvF9iTDjhood6gjCMJe-jqEiKeTxJn-fpOM0egzjI8o9kFvxPsnyaZME8GSevRT4P4qyIp3mWvhXX6GKha-9uDn2A3idJMX4JZ_k0Hcez0FKGZSiYKA11REtCcCkJpUZYDqANl9gAMzgC4igtuWNkNIpAg2DUlrIbmMgaMkAP-7vfzeZn63yrVpW3rq712m22XvFIQvcj6ECyB22z8b5xC_XdVCvd_CrAaheWOglLUaZ2YXVbd4fzW7Ny5XHnkE6n3x907a2uF41e28ofMdolzWjUYbM9tvSt_nRHXTedW-1OrUEysbPn-7J7xRGzX7pRbk3-AMwDilU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75917371</pqid></control><display><type>article</type><title>TETRAFIBRICIN, A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST: I. TAXONOMY, FERMENTATION, ISOLATION, CHARACTERIZATION AND BIOLOGICAL ACTIVITIES</title><source>MEDLINE</source><source>J-STAGE (Japan Science &amp; Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><creator>KAMIYAMA, TSUTOMU ; UMINO, TAKAYUKI ; FUJISAKI, NORIKO ; FUJIMORI, KUMIKO ; SATOH, TOMOKO ; YAMASHITA, YUKO ; OHSHIMA, SHOICHI ; WATANABE, JUNKO ; YOKOSE, KAZUTERU</creator><creatorcontrib>KAMIYAMA, TSUTOMU ; UMINO, TAKAYUKI ; FUJISAKI, NORIKO ; FUJIMORI, KUMIKO ; SATOH, TOMOKO ; YAMASHITA, YUKO ; OHSHIMA, SHOICHI ; WATANABE, JUNKO ; YOKOSE, KAZUTERU</creatorcontrib><description>Tetrafibricin is a novel fibrinogen receptor antagonist produced by Streptomyces neyagawaensis NR0577. It was isolated from the culture broth by Diaion HP-21 adsorption, MeOH extraction, MCI GEL CHP-20P column chromatography, preparative HPLC and Toyopearl HW-40 SF column chromatography. The physico-chemical properties of tetrafibricin indicated that the structure of tetrafibricin is different from the known peptide fibrinogen receptor antagonists and closely related to the polyene macrolide antibiotics. Tetrafibricin strongly inhibited the binding of fibrinogen to its receptors with an IC50 of 46 nM. It also inhibited ADP-, collagen-, and thrombin-induced aggregation of human platelets with IC50s of 5.6, 11.0 and 7.6μM, respectively.</description><identifier>ISSN: 0021-8820</identifier><identifier>EISSN: 1881-1469</identifier><identifier>DOI: 10.7164/antibiotics.46.1039</identifier><identifier>PMID: 8360097</identifier><identifier>CODEN: JANTAJ</identifier><language>eng</language><publisher>Tokyo: JAPAN ANTIBIOTICS RESEARCH ASSOCIATION</publisher><subject>Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - isolation &amp; purification ; Anti-Bacterial Agents - pharmacology ; Antibiotics, microbial producers, chemotherapic agents, antiseptics, disinfecting agents ; Applied microbiology ; Biological and medical sciences ; Chemical Phenomena ; Chemistry, Physical ; Chemotherapic agents ; Fermentation ; Fundamental and applied biological sciences. Psychology ; Humans ; In Vitro Techniques ; Macrolides ; Microbiology ; Platelet Membrane Glycoproteins - antagonists &amp; inhibitors ; Streptomyces - classification ; Streptomyces - metabolism</subject><ispartof>The Journal of Antibiotics, 1993/07/25, Vol.46(7), pp.1039-1046</ispartof><rights>Japan Antibiotics Research Association</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4609-868db4e3a9330d9344b8c711ab790b16b0513e44d7e632251a1864cd9d7eb5cb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4881645$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8360097$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KAMIYAMA, TSUTOMU</creatorcontrib><creatorcontrib>UMINO, TAKAYUKI</creatorcontrib><creatorcontrib>FUJISAKI, NORIKO</creatorcontrib><creatorcontrib>FUJIMORI, KUMIKO</creatorcontrib><creatorcontrib>SATOH, TOMOKO</creatorcontrib><creatorcontrib>YAMASHITA, YUKO</creatorcontrib><creatorcontrib>OHSHIMA, SHOICHI</creatorcontrib><creatorcontrib>WATANABE, JUNKO</creatorcontrib><creatorcontrib>YOKOSE, KAZUTERU</creatorcontrib><title>TETRAFIBRICIN, A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST: I. TAXONOMY, FERMENTATION, ISOLATION, CHARACTERIZATION AND BIOLOGICAL ACTIVITIES</title><title>Journal of antibiotics</title><addtitle>J. Antibiot.</addtitle><description>Tetrafibricin is a novel fibrinogen receptor antagonist produced by Streptomyces neyagawaensis NR0577. It was isolated from the culture broth by Diaion HP-21 adsorption, MeOH extraction, MCI GEL CHP-20P column chromatography, preparative HPLC and Toyopearl HW-40 SF column chromatography. The physico-chemical properties of tetrafibricin indicated that the structure of tetrafibricin is different from the known peptide fibrinogen receptor antagonists and closely related to the polyene macrolide antibiotics. Tetrafibricin strongly inhibited the binding of fibrinogen to its receptors with an IC50 of 46 nM. It also inhibited ADP-, collagen-, and thrombin-induced aggregation of human platelets with IC50s of 5.6, 11.0 and 7.6μM, respectively.</description><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - isolation &amp; purification</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics, microbial producers, chemotherapic agents, antiseptics, disinfecting agents</subject><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>Chemical Phenomena</subject><subject>Chemistry, Physical</subject><subject>Chemotherapic agents</subject><subject>Fermentation</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Macrolides</subject><subject>Microbiology</subject><subject>Platelet Membrane Glycoproteins - antagonists &amp; inhibitors</subject><subject>Streptomyces - classification</subject><subject>Streptomyces - metabolism</subject><issn>0021-8820</issn><issn>1881-1469</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkF9PwjAUxRujQUQ_gTHZg_HJYS_t-udxkoFLyGZw-tq0XdGRAbqOB7-9Qwjh5d7knt-9pz0I3QIecmD0Sa_bylSbtrJ-SNkQMJFnqA9CQAiUyXPUx3gEoRAjfImuvF9iTDjhood6gjCMJe-jqEiKeTxJn-fpOM0egzjI8o9kFvxPsnyaZME8GSevRT4P4qyIp3mWvhXX6GKha-9uDn2A3idJMX4JZ_k0Hcez0FKGZSiYKA11REtCcCkJpUZYDqANl9gAMzgC4igtuWNkNIpAg2DUlrIbmMgaMkAP-7vfzeZn63yrVpW3rq712m22XvFIQvcj6ECyB22z8b5xC_XdVCvd_CrAaheWOglLUaZ2YXVbd4fzW7Ny5XHnkE6n3x907a2uF41e28ofMdolzWjUYbM9tvSt_nRHXTedW-1OrUEysbPn-7J7xRGzX7pRbk3-AMwDilU</recordid><startdate>1993</startdate><enddate>1993</enddate><creator>KAMIYAMA, TSUTOMU</creator><creator>UMINO, TAKAYUKI</creator><creator>FUJISAKI, NORIKO</creator><creator>FUJIMORI, KUMIKO</creator><creator>SATOH, TOMOKO</creator><creator>YAMASHITA, YUKO</creator><creator>OHSHIMA, SHOICHI</creator><creator>WATANABE, JUNKO</creator><creator>YOKOSE, KAZUTERU</creator><general>JAPAN ANTIBIOTICS RESEARCH ASSOCIATION</general><general>Japan Antibiotics Research Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1993</creationdate><title>TETRAFIBRICIN, A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST</title><author>KAMIYAMA, TSUTOMU ; UMINO, TAKAYUKI ; FUJISAKI, NORIKO ; FUJIMORI, KUMIKO ; SATOH, TOMOKO ; YAMASHITA, YUKO ; OHSHIMA, SHOICHI ; WATANABE, JUNKO ; YOKOSE, KAZUTERU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4609-868db4e3a9330d9344b8c711ab790b16b0513e44d7e632251a1864cd9d7eb5cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - isolation &amp; purification</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics, microbial producers, chemotherapic agents, antiseptics, disinfecting agents</topic><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>Chemical Phenomena</topic><topic>Chemistry, Physical</topic><topic>Chemotherapic agents</topic><topic>Fermentation</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Macrolides</topic><topic>Microbiology</topic><topic>Platelet Membrane Glycoproteins - antagonists &amp; inhibitors</topic><topic>Streptomyces - classification</topic><topic>Streptomyces - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KAMIYAMA, TSUTOMU</creatorcontrib><creatorcontrib>UMINO, TAKAYUKI</creatorcontrib><creatorcontrib>FUJISAKI, NORIKO</creatorcontrib><creatorcontrib>FUJIMORI, KUMIKO</creatorcontrib><creatorcontrib>SATOH, TOMOKO</creatorcontrib><creatorcontrib>YAMASHITA, YUKO</creatorcontrib><creatorcontrib>OHSHIMA, SHOICHI</creatorcontrib><creatorcontrib>WATANABE, JUNKO</creatorcontrib><creatorcontrib>YOKOSE, KAZUTERU</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antibiotics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KAMIYAMA, TSUTOMU</au><au>UMINO, TAKAYUKI</au><au>FUJISAKI, NORIKO</au><au>FUJIMORI, KUMIKO</au><au>SATOH, TOMOKO</au><au>YAMASHITA, YUKO</au><au>OHSHIMA, SHOICHI</au><au>WATANABE, JUNKO</au><au>YOKOSE, KAZUTERU</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TETRAFIBRICIN, A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST: I. TAXONOMY, FERMENTATION, ISOLATION, CHARACTERIZATION AND BIOLOGICAL ACTIVITIES</atitle><jtitle>Journal of antibiotics</jtitle><addtitle>J. Antibiot.</addtitle><date>1993</date><risdate>1993</risdate><volume>46</volume><issue>7</issue><spage>1039</spage><epage>1046</epage><pages>1039-1046</pages><issn>0021-8820</issn><eissn>1881-1469</eissn><coden>JANTAJ</coden><abstract>Tetrafibricin is a novel fibrinogen receptor antagonist produced by Streptomyces neyagawaensis NR0577. It was isolated from the culture broth by Diaion HP-21 adsorption, MeOH extraction, MCI GEL CHP-20P column chromatography, preparative HPLC and Toyopearl HW-40 SF column chromatography. The physico-chemical properties of tetrafibricin indicated that the structure of tetrafibricin is different from the known peptide fibrinogen receptor antagonists and closely related to the polyene macrolide antibiotics. Tetrafibricin strongly inhibited the binding of fibrinogen to its receptors with an IC50 of 46 nM. It also inhibited ADP-, collagen-, and thrombin-induced aggregation of human platelets with IC50s of 5.6, 11.0 and 7.6μM, respectively.</abstract><cop>Tokyo</cop><pub>JAPAN ANTIBIOTICS RESEARCH ASSOCIATION</pub><pmid>8360097</pmid><doi>10.7164/antibiotics.46.1039</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-8820
ispartof The Journal of Antibiotics, 1993/07/25, Vol.46(7), pp.1039-1046
issn 0021-8820
1881-1469
language eng
recordid cdi_proquest_miscellaneous_75917371
source MEDLINE; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese
subjects Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - isolation & purification
Anti-Bacterial Agents - pharmacology
Antibiotics, microbial producers, chemotherapic agents, antiseptics, disinfecting agents
Applied microbiology
Biological and medical sciences
Chemical Phenomena
Chemistry, Physical
Chemotherapic agents
Fermentation
Fundamental and applied biological sciences. Psychology
Humans
In Vitro Techniques
Macrolides
Microbiology
Platelet Membrane Glycoproteins - antagonists & inhibitors
Streptomyces - classification
Streptomyces - metabolism
title TETRAFIBRICIN, A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST: I. TAXONOMY, FERMENTATION, ISOLATION, CHARACTERIZATION AND BIOLOGICAL ACTIVITIES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T11%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TETRAFIBRICIN,%20A%20NOVEL%20FIBRINOGEN%20RECEPTOR%20ANTAGONIST:%20I.%20TAXONOMY,%20FERMENTATION,%20ISOLATION,%20CHARACTERIZATION%20AND%20BIOLOGICAL%20ACTIVITIES&rft.jtitle=Journal%20of%20antibiotics&rft.au=KAMIYAMA,%20TSUTOMU&rft.date=1993&rft.volume=46&rft.issue=7&rft.spage=1039&rft.epage=1046&rft.pages=1039-1046&rft.issn=0021-8820&rft.eissn=1881-1469&rft.coden=JANTAJ&rft_id=info:doi/10.7164/antibiotics.46.1039&rft_dat=%3Cproquest_cross%3E75917371%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75917371&rft_id=info:pmid/8360097&rfr_iscdi=true